ONASEMNOGENE ABEPARVOVEC-BRVE
Drug approval information sourced from the PBS. Updated nightly from public government registries. Not medical advice.
Access in Australia
- This medicine is listed on the PBS, first listed 1 May 2022, according to the Pharmaceutical Benefits Scheme. Your doctor can advise whether a PBS-subsidised option is appropriate for you.
- TGA registration data for this medicine is not yet available on Voxsanity.
How it works: Gene Transduction or Replacement
Drug class: Other drugs for disorders of the musculo-skeletal system
Approval status
PBS Listed
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.
Accessing this drug in Australia
This drug is listed on the PBS. Available on a standard prescription from your GP.
This information is drawn from publicly available PBS records. It is not medical advice. Consult your doctor about access options for your specific situation.
Approval data sourced from the PBS. Updated nightly. This page does not constitute medical advice. Drug availability and PBS listing status may change. Verify current availability and PBS coverage with your doctor or pharmacist.